ImmunityBio (IBRX)
(Delayed Data from NSDQ)
$6.42 USD
-0.19 (-2.87%)
Updated May 31, 2024 04:00 PM ET
After-Market: $6.45 +0.03 (0.47%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, ImmunityBio (IBRX) reported earnings of -$0.20 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 25.00%. Look out for IBRX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 39.29%.
Earnings History
Price & Consensus
Zacks News for IBRX
ImmunityBio (IBRX)'s Technical Outlook is Bright After Key Golden Cross
IBRX: What are Zacks experts saying now?
Zacks Private Portfolio Services